Andrea Kassner1,2, Jackie Leung2,
1Medical Imaging,
University of Toronto, Toronto, Ontario, Canada; 2Diagnostic
Imaging, the Hospital for Sick Children, Toronto, Ontario, Canada; 3Respiratory
therapy, the Hospital for Sick Children, Toronto, Ontario, Canada; 4Thornhill
Research Inc., Toronto, Ontario, Canada; 5Physiology, University
of Toronto, Toronto, Ontario, Canada; 6Neurology, Hospital for
Sick Children, Toronto, Ontario, Canada; 7Hematology, Hospital for
Sick Children, Toronto, Ontario, Canada
Sickle cell disease (SCD) is the major cause of stroke in children leading to mortality or long-term disability. A noninvasive means of measuring cerebral blood flow (CBF) reserve would facilitate assessment and clinical management of these patients. BOLD MRI has been used as a surrogate for CBF changes in response to a vasoactive stimulus such as partial pressure of CO2 (PCO2). However, within the pediatric population, CVR studies are not common. We imaged 11 SCD patients using a system able to target end-tidal PCO2 in synchrony with BOLD MRI, and found a strong concordance between CVR and angiographic findings.